Functional Brands Inc.
OperatingBiotech · West Hollywood, CA
Financials
FY2018–FY2025 (no data for FY2020, FY2021, FY2022, FY2023) · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Cap table
Share counts as of Dec 31, 2025| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Stock | 18,704,649 | 1 | 100.0% | $25.67Dec 2020 |
Shares outstanding over timein today's share terms
Principal holders% as the filing states it, Mar 27, 2026
- Eric Gripentrog710,924 Common Stock3.42%of
- Tariq Rahim174,496 Common Stock0.84%of
Sold to the crowd
- Reg CF · Dec 202068,089 shares at $25.67 in today's terms · sold as 1,248,663 shares at $1.40; since then a 1-for-18.3386 reverse split (Jan 2025)$1.7M
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
1 personNames and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 6 annual reports (FY2020–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 19 filings on EDGAR- Form 10-QAug 14, 20260001213900-26-089996EDGAR
- Form 10-QMay 15, 20260001213900-26-057934EDGAR
- Form 10-KMar 27, 20260001213900-26-035675EDGAR
- Form 10-QDec 15, 20250001213900-25-121689EDGAR
- Form DNov 10, 20250001213900-25-108065EDGAR
- Form DJun 8, 20230001837254-23-000003EDGAR
- Form C/AMay 2, 20230001837254-23-000001EDGAR
- Form DApr 22, 20220001837254-22-000001EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.